The new wearable technology can assess multiple cardiovascular metrics, including electrical impulses and blood flow, to alert patients and clinicians to worsening heart failure and other conditions.

Cardiosense, a medical AI company transforming cardiovascular disease management, today announced that the U.S. Food and Drug ...

Wearable devices are increasingly popular for health monitoring via electrocardiograms (ECGs) as they can portably monitor heart conditions over a long time. However, so far there are no publicly ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that the Category III ...